Financials data is unavailable for this security.
Cash flow in USDView more
In 2024, cash reserves at Portage Biotech Inc fell by 5.52m. Cash Flow from Financing totalled 5.97m or -- of revenues. In addition the company used 14.30m for operations while cash from investing totalled 2.81m.
Cash flow per share | -70.51 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.39 |
---|---|
Tangible book value per share | 2.39 |
More ▼
Balance sheet in USDView more
Current ratio | 1.73 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0147 |
---|---|
Total debt/total capital | 0.02 |
More ▼